Arpita Desai, Medical Director of GU Medical Oncology, Associate Professor at UC San Francisco, shared a post on X:
“Grateful to the IK Cancer Summit Kidney Cancer community for an inspiring meeting and the opportunity to speak on advancing care in refractory RCC!
Always incredible to be surrounded by colleagues who push the field forward. Also proud to share our poster on Equity in Genomic Integration and Outcomes in DDR-mutant mRCC. Equity isn’t optional — it’s essential to true progress.
Leaving IKCS energized, motivated, and ready to keep driving innovation, inclusion, and hope for every RCC patient.”
More posts featuring Arpita Desai.
